FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism

Main|Home|PHGKB




Last Posted: Nov 01, 2018

---

• FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism
  FDA Press Release, October 31, 2018
• FDA clears the first consumer genetic test for how well your medications may work — with caveats
  R Robbins, StatNews, October 31, 2018
• Pharmacogenomics: What does it mean for your health
  CDC, October 2018
• Implementing Clinical Pharmacogenomics in the Classroom: Student Pharmacist Impressions of an Educational Intervention Including Personal Genotyping.
  Frick Amber et al. Pharmacy (Basel, Switzerland) 2018 Oct 6(4)
• Current landscape of personalized medicine adoption and implementation in Southeast Asia.
  Chong Huey Yi et al. BMC medical genomics 2018 Oct 11(1) 94
• Metformin transporter pharmacogenomics: insights into drug disposition - where are we now?
  Chan Paul et al. Expert opinion on drug metabolism & toxicology 2018 Oct
• Pharmacies selling DNA tests to help patients pick best medications
  CBC, October 25, 2018
• Implementing a personalized medicine program in a community health system.
  Dressler Lynn G et al. Pharmacogenomics 2018 Oct
• Pharmacogenomics and Biomarkers of Depression.
  Jha Manish K et al. Handbook of experimental pharmacology 2018 Oct
• Going to the negative: genomics for optimized medical prescription
  G Gibson, Nat Rev Genetics, October 23, 2018

more